Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats. Baskal S*, Büttner P*, Werner S, Besler C, Lurz P, Thiele H, Tsikas D Amino Acids 2021; (0): 1-10 ISSN 0939-4451 Impact factor: 3.520
Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction. Besler C, Rommel KP, Kresoja KP, Mörbitz J, Kirsten H, Scholz M, Klingel K, Thiery J, Burkhardt R, Büttner P, Adams V, Thiele H, Lurz P ESC Heart Fail 2021; 8(3): 1861-1872 ISSN 2055-5822 Impact factor: 4.411
Biventricular Physiology of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Edge-to-Edge Repair. Blazek S, Unterhuber M, Rommel KP, von Roeder M, Kresoja KP, Kister T, Besler C, Fengler K, Sandri M, Daehnert I, Thiele H, Lurz P JACC Cardiovasc Interv 2021; 14(1): 54-66 ISSN 1936-8798 Impact factor: 11.195
Hospitalisations for emergency-sensitive conditions in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Bollmann A, Hohenstein S, Pellissier V, König S, Ueberham L, Hindricks G, Meier-Hellmann A, Kuhlen R Emerg Med J 2021; 38(11): 846-850 ISSN 1472-0205 Impact factor: 2.794
Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network. Bollmann A, Hohenstein S, Pellissier V, Stengler K, Reichardt P, Ritz JP, Thiele H, Borger MA, Hindricks G, Meier-Hellmann A, Kuhlen R PLoS One 2021; 16(3): e0249251 ISSN 1932-6203 Impact factor: 3.240
Cumulative hospitalization deficit for cardiovascular disorders in Germany during the Covid-19 pandemic. Bollmann A, Pellissier V, Hohenstein S, König S, Ueberham L, Meier-Hellmann A, Kuhlen R, Thiele H, Hindricks G Eur Heart J Qual Care Clin Outcomes 2021; 7(4): e5-e6 ISSN 2058-5225 Impact factor: 4.370
Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Bollmann A, Pellissier V, Hohenstein S, König S, Ueberham L, Meier-Hellmann A, Kuhlen R, Thiele H, Hindricks G Eur Heart J Qual Care Clin Outcomes 2021; 7(4): e5-e6 ISSN 2058-5225 Impact factor: 4.370
Structural and functional alterations in heart and skeletal muscle following severe TAC in mice: impact of moderate exercise training. Böttner J, Werner S, Adams V, Knauth S, Kricke A, Thiele H, Büttner P Biol Res 2021; 54(1): 31 ISSN 0716-9760 Impact factor: 5.612
Correction to: Arginine derivatives in atrial fibrillation progression phenotypes. Büttner P, Bahls M, Böger RH, Hindricks G, Thiele H, Schwedhelm E, Kornej J J Mol Med (Berl) 2021; 99(12): 1829 ISSN 0946-2716 Impact factor: 4.380
Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis. Büttner P, Feistner L, Lurz P, Thiele H, Hutcheson JD, Schlotter F Front Cardiovasc Med 2021; 8: 660797 ISSN 2297-055X Impact factor: 6.050
Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction. Büttner P, Werner S, Baskal S, Tsikas D, Adams V, Lurz P, Besler C, Knauth S, Bahls M, Schwedhelm E, Thiele H Sci Rep 2021; 11(1): 20684 ISSN 2045-2322 Impact factor: 4.380
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction. Ceglarek U, Schellong P, Rosolowski M, Scholz M, Willenberg A, Kratzsch J, Zeymer U, Fuernau G, de Waha-Thiele S, Büttner P, Jobs A, Freund A, Desch S, Feistritzer HJ, Isermann B, Thiery J, Pöss J, Thiele H Eur Heart J 2021; 42(24): 2344-2352 ISSN 0195-668X Impact factor: 29.983
Major bleeding and the ADP-binding enzyme creatine kinase in non-ST-segment elevation acute coronary syndromes. Collet JP, Thiele H Eur Heart J 2021; 42(23): 2313-2314 ISSN 0195-668X Impact factor: 29.983
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation. Collet JP, Thiele H Eur Heart J 2021; 42(20): 2020-2021 ISSN 0195-668X Impact factor: 29.983
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified? Collet JP, Thiele H Eur Heart J 2021; 42(26): 2611-2612 ISSN 0195-668X Impact factor: 29.983
Lesson learnt from the new 2020 ESC guidelines on non-ST-segment elevation acute coronary syndrome: when clinical judgement precedes and overpasses weak recommendations. 2020 non-ST-segment elevation acute coronary syndrome guidelines on pre-treatment: primum non nocere! Collet JP, Thiele H Eur Heart J 2021; 42(26): 2607-2608 ISSN 0195-668X Impact factor: 29.983
Validation of the VT-LVAD score for prediction of late VAs in LVAD recipients. Darma A, Arya A, Dagres N, Kühl M, Hindricks G, Eifert S, Saeed D, Borger M, Martins RP, Leclercq C, Galand V J Cardiovasc Electrophysiol 2021; 32(2): 515-522 ISSN 1045-3873 Impact factor: 2.871
Role of assist device implantation and heart transplantation in the long-term outcome of patients with structural heart disease after catheter ablation of ventricular tachycardia. Darma A, Bertagnolli L, Dinov B, Shamloo AS, Torri F, Efimova E, Dagres N, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A Herzschrittmacherther Elektrophysiol 2021; 32(3): 353-358 ISSN 0938-7412 Impact factor: 0.530
VT ablation in geriatric patients with structural heart disease: Should there still be an age limit? Darma A, Bertagnolli L, Dinov B, Torri F, Dagres N, Bollmann A, Hindricks G, Arya A J Cardiovasc Electrophysiol 2021; 32(3): 766-771 ISSN 1045-3873 Impact factor: 2.871
Gender differences in patients with structural heart disease undergoing VT ablation. Darma A, Bertagnolli L, Torri F, Lurz JA, König S, Ueberham L, Bollmann A, Dagres N, Hindricks G, Dinov B, Arya A J Cardiovasc Electrophysiol 2021; 32(10): 2675-2683 ISSN 1045-3873 Impact factor: 2.871
Epicardial ablation of ventricular tachycardia in patients with structural heart disease: a single-centre experience over 12 years. Darma A, Bertagnolli L, Weber A, Dinov B, Torri F, Lurz JA, Shamloo AS, Dagres N, Bollmann A, Hindricks G, Arya A Europace 2021; 23(12): 1980-1988 ISSN 1099-5129 Impact factor: n.n.e.
Dynamic changes in the signal-averaged electrocardiogram are associated with the long-term outcomes after ablation of ischemic ventricular tachycardia. Dinov B*, Schramm L*, Koenig S, Oebel S, Bollmann A, Hindricks G, Arya A, Bode K J Interv Card Electrophysiol 2021; 60(1): 125-134 ISSN 1383-875X Impact factor: 1.900
Correction to: Dynamic changes in the signal-averaged electrocardiogram are associated with the long-term outcomes after ablation of ischemic ventricular tachycardia. Dinov B, Schramm L, Koenig S, Oebel S, Bollmann A, Hindricks G, Arya A, Bode K J Interv Card Electrophysiol 2021; 62(1): 217 ISSN 1383-875X Impact factor: 1.900
Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement. Feistritzer HJ, Kurz T, Stachel G, Hartung P, Lurz P, Eitel I, Marquetand C, Nef H, Doerr O, Vigelius-Rauch U, Lauten A, Landmesser U, Treskatsch S, Abdel-Wahab M, Sandri M, Holzhey D, Borger M, Ender J, Ince H, Öner A, Meyer-Saraei R, Hambrecht R, Wienbergen H, Fach A, Augenstein T, Frey N, König IR, Vonthein R, Funkat AK, Berggreen AE, Heringlake M, Desch S, de Waha-Thiele S, Thiele H J Am Coll Cardiol 2021; 77(17): 2204-2215 ISSN 0735-1097 Impact factor: 24.093
Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant Hypertension. Fengler K, Reimann P, Rommel KP, Kresoja KP, Blazek S, Unterhuber M, Besler C, von Roeder M, Böhm M, Desch S, Thiele H, Lurz P J Am Heart Assoc 2021; 10(21): e022429 ISSN 2047-9980 Impact factor: 5.501
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Freedman B*, Hindricks G*, Banerjee A, Baranchuk A, Ching CK, Du X, Fitzsimons D, Healey JS, Ikeda T, Lobban TCA, Mbakwem A, Narasimhan C, Neubeck L, Noseworthy P, Philbin DM Jr, Pinto FJ, Rwebembera J, Schnabel RB, Svendsen JH, Aguinaga L, Arbelo E, Böhm M, Farhan HA, Hobbs FDR, MartÃnez-Rubio A, Militello C, Naik N, Noubiap JJ, Perel P, Pi?eiro DJ, Ribeiro AL, Stepinska J Glob Heart 2021; 16(1): 41 ISSN 2211-8160 Impact factor: 3.426
Comparison of risk prediction models in infarct-related cardiogenic shock. Freund A, Pöss J, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Feistritzer HJ, Rubini M, Huber K, Windecker S, Montalescot G, Oldroyd K, Noc M, Zeymer U, Ouarrak T, Schneider S, Baran DA, Desch S, Thiele H Eur Heart J Acute Cardiovasc Care 2021; 10(8): 890-897 ISSN 2048-8726 Impact factor: 4.696
Reply: Early Recognition and Intervention Are Critical for Patients in Cardiogenic Shock. Fuernau G, Eitel I, Zeymer U, Thiele H JACC Cardiovasc Interv 2021; 14(1): 109-110 ISSN 1936-8798 Impact factor: 11.195
Impact of timing of intraaortic balloon counterpulsation on mortality in cardiogenic shock - a subanalysis of the IABP-SHOCK II trial. Fuernau G, Ledwoch J, Desch S, Eitel I, Thelemann N, Jung C, de Waha-Thiele S, Pöss J, Feistritzer HJ, Freund A, Schneider S, Ouarrak T, Werdan K, Zeymer U, Thiele H Eur Heart J Acute Cardiovasc Care 2021; 10(1): 54-61 ISSN 2048-8726 Impact factor: 4.696
Novel Pacemaker-Mediated Arrhythmia Without Ventriculoatrial Conduction Can Induce Atrial Fibrillation. Gjermeni E, Doering M, Richter S, Hindricks G, Bode K JACC Clin Electrophysiol 2021; 7(1): 1-5 ISSN 2405-500X Impact factor: 6.375
[Cardiology: overcome boundaries, discover new worlds]. Hilfiker-Kleiner D, Thiele H Herz 2021; 46(2): 105-106 ISSN 0340-9937 Impact factor: 1.443
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL Eur Heart J 2021; 42(5): 373-498 ISSN 0195-668X Impact factor: 29.983
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL Eur Heart J 2021; 42(40): 4194 ISSN 0195-668X Impact factor: 29.983
Anti-inflammatory HDL effects are impaired in atrial fibrillation. Holzwirth E, Fischer-Schaepmann T, Obradovic D, von Lucadou M, Schwedhelm E, Daum G, Hindricks G, Marsche G, Trieb M, Thiele H, Kornej J, Büttner P Heart Vessels 2021; (1): 1-11 ISSN 0910-8327 Impact factor: 2.037
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic. Husser D, Hohenstein S, Pellissier V, König S, Ueberham L, Hindricks G, Meier-Hellmann A, Kuhlen R, Bollmann A Thromb Res 2021; 202(): 145-147 ISSN 0049-3848 Impact factor: 3.944
Potential Contributors to Increased Pulmonary Embolism Hospitalizations During the COVID-19 Pandemic: Insights From the German-Wide Helios Hospital Network. Husser D, Hohenstein S, Pellissier V, Ueberham L, König S, Hindricks G, Meier-Hellmann A, Kuhlen R, Bollmann A Front Cardiovasc Med 2021; 8: 715761 ISSN 2297-055X Impact factor: 6.050
Hospital care of patients with inherited cardiomyopathies in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network. Husser D, Pellissier V, Hohenstein S, Ueberham L, König S, Hindricks G, Meier-Hellmann A, Kuhlen R, Bollmann A Am J Med Genet A 2021; 185(7): 2278-2282 ISSN 1552-4825 Impact factor: 2.802
Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data? Jobs A, Collet JP, Thiele H Eur Heart J 2021; 42(4): 353-354 ISSN 0195-668X Impact factor: 29.983
Deep Sedation versus General Anaesthesia for Transcatheter Mitral Valve Repair: An Individual-Patient Data Meta-analysis of Observational Studies. Jobs A, Grund S, de Waha-Thiele S, Ledwoch J, Sievert H, Rassaf T, Luedike P, Kelm M, Hellhammer K, Horn P, Westenfeld R, Patzelt J, Langer HF, Lurz P, Desch S, Eitel I, Thiele H EuroIntervention 2021; 16(16): 1359-1365 ISSN 1774-024X Impact factor: 6.534
Bail-out edge-to-edge mitral repair for an acute single leaflet device attachment: a case report. Kitamura M, Besler C, Lurz P, Noack T Eur Heart J Case Rep 2021; 5(4): 147 ISSN 2514-2119 Impact factor: 0.550
12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Kitamura M, Fam NP, Braun D, Ruf T, Sugiura A, Narang A, Connelly KA, Ho E, Nabauer M, Hausleiter J, Weber M, Nickenig G, Davidson CJ, Thiele H, von Bardeleben RS, Lurz P Catheter Cardiovasc Interv 2021; 97(6): 1281-1289 ISSN 1522-1946 Impact factor: 2.692
Single leaflet BASILICA for bilateral coronary artery protection. Kitamura M, Holzhey D, Thiele H, Abdel-Wahab M Eur Heart J 2021; 42(26): 2612 ISSN 0195-668X Impact factor: 29.983
Impact of Tricuspid Valve Morphology on Clinical Outcomes After Transcatheter Edge-to-Edge Repair. Kitamura M, Kresoja KP, Besler C, Leontyev S, Kiefer P, Rommel KP, Otto W, Forner AF, Ender J, Holzhey DM, Abdel-Wahab M, Thiele H, Borger MA, Hahn RT, Lurz P, Noack T JACC Cardiovasc Interv 2021; 14(14): 1616-1618 ISSN 1936-8798 Impact factor: 11.195
Quantitative assessment of aortic regurgitation following transcatheter aortic valve replacement. Kitamura M, Von Roeder M, Abdel-Wahab M Expert Rev Cardiovasc Ther 2021; 19(7): 633-645 ISSN 1477-9072 Impact factor: 2.230
Patient-Specific Neocommissural Alignment of the Evolut Valve: A Pilot Study in Transcatheter Aortic Valve-in-Valve Replacement. Kitamura M, Wilde J, Dumpies O, Gutberlet M, Gohmann R, Shibata M, Noack T, Thiele H, Holzhey D, Abdel-Wahab M JACC Cardiovasc Interv 2021; 14(8): 934-936 ISSN 1936-8798 Impact factor: 11.195
Commissural Alignment of the ACURATE neo Valve in Transcatheter Aortic Valve Replacement. Kitamura M, Wilde J, Gohmann R, Majunke N, Gutberlet M, Shibata M, Kiefer P, Desch S, Thiele H, Holzhey D, Abdel-Wahab M JACC Cardiovasc Interv 2021; 14(15): 1740-1742 ISSN 1936-8798 Impact factor: 11.195
Digital health solutions in the screening of subclinical atrial fibrillation. König S, Bollmann A, Hindricks G Herz 2021; 46(4): 329-335 ISSN 0340-9937 Impact factor: 1.443
Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19? König S, Hohenstein S, Ueberham L, Hindricks G, Meier-Hellmann A, Kuhlen R, Bollmann A J Infect 2021; 82(5): 186-230 ISSN 0163-4453 Impact factor: 6.072
Machine learning algorithms for claims data-based prediction of in-hospital mortality in patients with heart failure. König S, Pellissier V, Hohenstein S, Bernal A, Ueberham L, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A ESC Heart Fail 2021; 8(4): 3026-3036 ISSN 2055-5822 Impact factor: 4.411
Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey. König S, Svetlosak M, Grabowski M, Duncker D, Nagy VK, Bogdan S, Vanduynhoven P, Sohaib SMA, Malaczynska-Raipold K, Lane DA, Lenarczyk R, Bollmann A, Hindricks G, Potpara TS, Kosiuk J Europace 2021; 23(1): 149-156 ISSN 1099-5129 Impact factor: 5.214
Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network. König S, Ueberham L, Pellissier V, Hohenstein S, Meier-Hellmann A, Thiele H, Ahmadli V, Borger MA, Kuhlen R, Hindricks G, Bollmann A Clin Cardiol 2021; 44(3): 392-400 ISSN 0160-9289 Impact factor: 2.882
Remote ischemic preconditioning in a setting of electrical cardioversion of early onset persistent atrial fibrillation (RIP CAF trial): Rationale and study design. Kosiuk J, Langenhan K, Hindricks G, Bollmann A, Dagres N J Cardiol 2021; 77(1): 79-82 ISSN 0914-5087 Impact factor: 2.246
Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction. Kresoja KP, Rommel KP, Fengler K, von Roeder M, Besler C, Lücke C, Gutberlet M, Desch S, Thiele H, Böhm M, Lurz P Circ Heart Fail 2021; 14(3): e007421 ISSN 1941-3289 Impact factor: 8.846
Right Ventricular Contraction Patterns in Patients Undergoing Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation. Kresoja KP, Rommel KP, Lücke C, Unterhuber M, Besler C, von Roeder M, Schöber AR, Noack T, Gutberlet M, Thiele H, Lurz P JACC Cardiovasc Interv 2021; 14(14): 1551-1561 ISSN 1936-8798 Impact factor: 11.195
Response to the letter regarding the article Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Kresoja KP, Rommel KP, Thiele H, Lurz P Eur J Heart Fail 2021; 23(4): 680-681 ISSN 1388-9842 Impact factor: 15.534
Ventricular Interaction in a Patient With Heart Failure With Preserved Ejection Fraction and Severe Tricuspid Regurgitation. Kresoja KP, Rommel KP, Thiele H, Lurz P Circ Heart Fail 2021; 14(10): e008768 ISSN 1941-3289 Impact factor: 8.846
Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction. Kresoja KP, Rommel KP, Wachter R, Henger S, Besler C, Klöting N, Schnelle M, Hoffmann A, Büttner P, Ceglarek U, Thiele H, Scholz M, Edelmann F, Blüher M, Lurz P Eur J Heart Fail 2021; 23(10): 1633-1644 ISSN 1388-9842 Impact factor: 15.543
[Current applications of hypnosis in the field of cardiac electrophysiology]. Lerche M, Sepehri Shamloo A, Hindricks G Herz 2021; 46(4): 336-341 ISSN 0340-9937 Impact factor: 1.443
[Pulmonary vein isolation in atrial fibrillation using pulsed field ablation]. Lindemann F, Nedios S, Seewöster T, Hindricks G Herz 2021; 46(4): 318-322 ISSN 0340-9937 Impact factor: 1.443
Optimal timing of contrast-enhanced three-dimensional magnetic resonance left atrial angiography before pulmonary vein ablation. Löbe S, Leuthäusser C, Pölkow A, Hilbert S, Sommer P, Bollmann A, Hindricks G, Paetsch I, Jahnke C Cardiol J 2021; 28(4): 558-565 ISSN 1897-5593 Impact factor: 1.320
Iron deficiency in heart failure. Loncar G*, Obradovic D*, Thiele H, von Haehling S, Lainscak M ESC Heart Fail 2021; 8(4): 2368-2379 ISSN 2055-5822 Impact factor: 4.411
Mitral Regurgitation in Cardiogenic Shock: A Novel Target for Transcatheter Therapy? Lurz P, Besler C JACC Cardiovasc Interv 2021; 14(1): 12-14 ISSN 1936-8798 Impact factor: 11.195
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. Lurz P, Stephan von Bardeleben R, Weber M, Sitges M, Sorajja P, Hausleiter J, Denti P, Trochu JN, Nabauer M, Tang GHL, Biaggi P, Ying SW, Trusty PM, Dahou A, Hahn RT, Nickenig G J Am Coll Cardiol 2021; 77(3): 229-239 ISSN 0735-1097 Impact factor: 24.093
Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial. Lurz P, Unterhuber M, Rommel KP, Kresoja KP, Kister T, Besler C, Fengler K, Sandri M, Daehnert I, Thiele H, von Roeder M, Blazek S Circulation 2021; 143: 292-294 ISSN 0009-7322 Impact factor: 23.603
Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy. Nedios S, Dinov B, Seewöster T, Lindemann F, Richter S, Arya A, Dagres N, Husser D, Bollmann A, Hindricks G, Müssigbrodt A Sci Rep 2021; 11(1): 12411 ISSN 2045-2322 Impact factor: 4.380
Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead? Nedios S, Doering M, Darma A, Lucas J, Dinov B, Arya A, Dagres N, Hindricks G, Bollmann A, Richter S, Bode K Clin Cardiol 2021; 44(2): 210-217 ISSN 0160-9289 Impact factor: 2.882
Atrial remodeling and atrial fibrillation recurrence after catheter ablation : Past, present, and future developments. Nedios S, Lindemann F, Heijman J, Crijns HJGM, Bollmann A, Hindricks G Herz 2021; 46(4): 312-317 ISSN 0340-9937 Impact factor: 1.443
Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function. Nedios S, Löbe S, Knopp H, Seewöster T, Heijman J, Crijns HJGM, Arya A, Bollmann A, Hindricks G, Dinov B Clin Cardiol 2021; 44(1): 116-122 ISSN 0160-9289 Impact factor: 2.248
Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function. Nedios S, Löbe S, Knopp H, Seewöster T, Heijman J, Crijns HJGM, Arya A, Bollmann A, Hindricks G, Dinov B Clin Cardiol 2021; 44(1): 116-122 ISSN 0160-9289 Impact factor: 2.882
Association of low-voltage areas with the regional wall deformation and the left atrial shape in patients with atrial fibrillation: A proof of concept study. Nedios S, Sanatkhani S, Oladosu M, Seewöster T, Richter S, Arya A, Heijman J, J G M Crijns H, Hindricks G, Bollmann A, Menon PG Int J Cardiol Heart Vasc 2021; 33: 100730 ISSN 2352-9067 Impact factor: 2.240
The potential role of plasma miR-155 and miR-206 as circulatory biomarkers in inflammatory cardiomyopathy. Obradovic D, Rommel KP, Blazek S, Klingel K, Gutberlet M, Lücke C, Büttner P, Thiele H, Adams V, Lurz P, Emrich F, Besler C ESC Heart Fail 2021; 8(3): 1850-1860 ISSN 2055-5822 Impact factor: 4.411
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better. Ohman EM, Zwischenberger BA, Thiele H JACC Cardiovasc Interv 2021; 14(10): 1120-1122 ISSN 1936-8798 Impact factor: 11.195
Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis. Orban M, Kleeberger J, Ouarrak T, Freund A, Feistritzer HJ, Fuernau G, Geisler T, Huber K, Dudek D, Noc M, Montalescot G, Neumer A, Haller P, Clemmensen P, Zeymer U, Desch S, Massberg S, Schneider S, Thiele H*, Hausleiter J* Clin Res Cardiol 2021; 110(9): 1493-1503 ISSN 1861-0684 Impact factor: 5.460
Durability of Transcatheter Heart Valves: Standardized Definitions and Available Data. Richter I, Thiele H, Abdel-Wahab M J Clin Med 2021; 10(18): 4180 ISSN 2077-0383 Impact factor: 4.242
Impact of electroanatomical mapping-guided lead implantation on procedural outcome of His bundle pacing. Richter S, Ebert M, Bertagnolli L, Gebauer R, Lucas J, Scheller D, Paetsch I, Hindricks G, Döring M Europace 2021; 23(3): 409-420 ISSN 1099-5129 Impact factor: 5.214
[Current technologies in interventional treatment of tricuspid valve regurgitation]. Rosch S, Lurz P Herz 2021; 46(5): 437-444 ISSN 0340-9937 Impact factor: 1.443
Is cryoballoon ablation in community hospitals the future for atrial fibrillation treatment? Schilling R, Bollmann A Europace 2021; 23(11): 1689-1690 ISSN 1099-5129 Impact factor: 5.214
ApoC-III is a novel inducer of calcification in human aortic valves. Schlotter F, de Freitas RCC, Rogers MA, Blaser MC, Wu PJ, Higashi H, Halu A, Iqbal F, Andraski AB, Rodia CN, Kuraoka S, Wen JR, Creager M, Pham T, Hutcheson JD, Body SC, Kohan AB, Sacks FM, Aikawa M, Singh SA, Aikawa E J Biol Chem 2021; 296: 100193 ISSN 0021-9258 Impact factor: 5.157
Biatrial volume ratio predicts low voltage areas in atrial fibrillation. Seewöster T, Dinov B, Nedios S, Hindricks G, Sommer P, Kornej J Clin Cardiol 2021; 44(11): 1560-1566 ISSN 0160-9289 Impact factor: 2.882
Prediction of low-voltage areas using modified APPLE score. Seewöster T, Kosich F, Sommer P, Bertagnolli L, Hindricks G, Kornej J Europace 2021; 23(4): 575-580 ISSN 1099-5129 Impact factor: 5.214
Abnormal pattern of left atrial activation and asynchronous conduction predicted the occurrence of new atrial fibrillation: evidences for Bachmann s bundle block in atrial fibrillation pathophysiology. Seewöster T, Marinov K, Löbe S, Knopp H, Nedios S, Bollmann A, Hindricks G, Dinov B Europace 2021; 23(8): 1244-1251 ISSN 1099-5129 Impact factor: 5.214
Atrial fibrillation: is there a role for cardiac troponin? Sepehri Shamloo A, Arya A, Darma A, Nedios S, Döring M, Bollmann A, Dagres N, Hindricks G Diagnosis (Berl) 2021; 8(3): 295-303 ISSN 2194-8011 Impact factor: 1.410
[2020 ESC guidelines on atrial fibrillation: Summary of the most relevant recommendations and innovations]. Sepehri Shamloo A, Dagres N, Hindricks G Herz 2021; 46(1): 28-37 ISSN 0340-9937 Impact factor: 1.443
Quantification of regurgitation in mitral valve prolapse with four-dimensional flow cardiovascular magnetic resonance. Spampinato RA, Jahnke C, Crelier G, Lindemann F, Fahr F, Czaja-Ziolkowska M, Sieg F, Strotdrees E, Hindricks G, Borger MA, Paetsch I J Cardiovasc Magn Reson 2021; 23(1): 87 ISSN 1097-6647 Impact factor: 5.364
Paravalvular Regurgitation According to Transcatheter Aortic Valve Prosthesis Type: Insights From the Randomized SOLVE-TAVI Trial. Stachel G, Abdel-Wahab M, de Waha-Thiele S, Desch S, Feistritzer HJ, Kitamura M, Eitel I, Kurz T, Thiele H JACC Cardiovasc Imaging 2021; 14(6): 1277-1279 ISSN 1936-878X Impact factor: 14.805
Left-Atrial Appendage Thrombosis in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Stachel G, Woitek FJ, Crusius L, Haussig S, Kiefer P, Leontyev S, Schlotter F, Spindler A, Höllriegel R, Hommel J, Borger MA, Thiele H, Holzhey D, Linke A, Mangner N Can J Cardiol 2021; 37(3): 450-457 ISSN 0828-282X Impact factor: 5.352
Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial. Stiermaier T, Schaefer P, Meyer-Saraei R, Saad M, de Waha-Thiele S, Pöss J, Fuernau G, Graf T, Kurz T, Frydrychowicz A, Barkhausen J, Desch S, Thiele H*, Eitel I* J Am Heart Assoc 2021; 10(9): e018881 ISSN 2047-9980 Impact factor: 5.501
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure. Stocker TJ, Hertell H, Orban M, Braun D, Rommel KP, Ruf T, Ong G, Nabauer M, Deseive S, Fam N, von Bardeleben RS, Thiele H, Massberg S, Lurz P*, Hausleiter J* JACC Cardiovasc Interv 2021; 14(1): 29-38 ISSN 1936-8798 Impact factor: 11.195
Catheter-directed therapy in pulmonary embolism. Sulimov DS, Freund A, Thiele H Herz 2021; 46(5): 399-405 ISSN 0340-9937 Impact factor: 1.443
Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation. Sulimov DS, Markuske M, Desch S, Thiele H Catheter Cardiovasc Interv 2021; 98(1): E122-E123 ISSN 1522-1946 Impact factor: 2.692
Predictors of Clinical Outcome After Early Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction. Szczanowicz L, Majunke N, de Waha-Thiele S, Tietz F, Schürer S, Kirsch K, Desch S, Thiele H, Sandri M J Invasive Cardiol 2021; 33(5): E329-E335 ISSN 1042-3931 Impact factor: 2.022
Management of cardiogenic shock. Thiele H, de Waha-Thiele S, Freund A, Zeymer U, Desch S, Fitzgerald S EuroIntervention 2021; 17(6): 451-465 ISSN 1774-024X Impact factor: 6.534
Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial. Thiele H, Freund A, Gimenez MR, de Waha-Thiele S, Akin I, Pöss J, Feistritzer HJ, Fuernau G, Graf T, Nef H, Hamm C, Böhm M, Lauten A, Schulze PC, Voigt I, Nordbeck P, Felix SB, Abel P, Baldus S, Laufs U, Lenk K, Landmesser U, Skurk C, Pieske B, Tschöpe C, Hennersdorf M, Wengenmayer T, Preusch M, Maier LS, Jung C, Kelm M, Clemmensen P, Westermann D, Seidler T, Schieffer B, Rassaf T, Mahabadi AA, Vasa-Nicotera M, Meincke F, Seyfarth M, Kersten A, Rottbauer W, Boekstegers P, Muellenbach R, Dengler Am Heart J 2021; 234: 1-11 ISSN 0002-8703 Impact factor: 4.749
[ESC guidelines 2020: acute coronary syndrome without persistent ST-segment elevation: What is new?] Thiele H, Jobs A Herz 2021; 46(1): 3-13 ISSN 0340-9937 Impact factor: 1.443
Anticoagulation in special patient populations with atrial fibrillation. Ueberham L, Hindricks G Herz 2021; 46(4): 323-328 ISSN 0340-9937 Impact factor: 1.443
Current Diagnostic Criteria Show a Substantial Disagreement in Classification of Patients With Suspected Cardiac Sarcoidosis. Ueberham L, Jahnke C, Paetsch I, Klingel K, Kuehl M, Hindricks G, Dinov B JACC Clin Electrophysiol 2021; 7(4): 538-539 ISSN 2405-500X Impact factor: 6.375
Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic-insights from the German-wide Helios hospital network. Ueberham L, König S, Pellissier V, Hohenstein S, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A Eur Heart J Qual Care Clin Outcomes 2021; 7(3): 257-264 ISSN 2058-5225 Impact factor: 4.370
Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis. Unterhuber M, Kresoja KP, Besler C, Rommel KP, Orban M, von Roeder M, Braun D, Stolz L, Massberg S, Trebicka J, Zachäus M, Hausleiter J, Thiele H, Lurz P Eur J Heart Fail 2021; 23(10): 1784-1794 ISSN 1388-9842 Impact factor: 15.543
Proteomics-Enabled Deep Learning Machine Algorithms Can Enhance Prediction of Mortality. Unterhuber M, Kresoja KP, Rommel KP, Besler C, Baragetti A, Klöting N, Ceglarek U, Blüher M, Scholz M, Catapano AL, Thiele H, Lurz P J Am Coll Cardiol 2021; 78(16): 1621-1631 ISSN 0735-1097 Impact factor: 24.093
Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project-a position paper. Willems D, Bak M, Tan H, Lindinger G, Kocar A, Seperhi Shamloo A, Schmidt G, Hindricks G, Dagres N Open Heart 2021; 8(2): e001686 ISSN 2053-3624 Impact factor: 2.450
Clinical outcomes according to ECG presentations in infarct-related cardiogenic shock in CULPRIT-SHOCK. Zeitouni M, Akin I, Desch S, Barthelemy O, Brugier D, Collet JP, de Waha-Thiele S, Greenwood JP, Guedeney P, Hage G, Hauguel-Moreau M, Huber K, Kerneis M, Noc M, Oldroyd KG, Piek JJ, Rouanet S, Savonitto S, Serpytis P, Silvain J, Stepinska J, Vicaut E, Vrints CJ, Windecker S, Zeymer U, Thiele H*, Montalescot G* Chest 2021; 159(4): 1415-1425 ISSN 0012-3692 Impact factor: 9.410
[COVID-19 pandemic : Effects on clinical care of cardiovascular patients in spring 2020]. Zeymer U, Gitt A, Thiele H Herz 2021; 46(2): 115-119 ISSN 0340-9937 Impact factor: 1.443
